Shanghai Kaibao Pharmaceutical CO.,Ltd at the Extraordinary General Meeting of 2020 held on 10 December 2020 approved the election of Zhou Yingbin, Zhao Ningbo and Fu Shizhong as non-independent directors, appointed Tao Jiansheng, Ye Zuguang and Li Zhengni as independent directors and appointed Zhao Keji as shareholder supervisor.